Literature DB >> 12970785

Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup.

M I Gutierrez1, A K Siraj, M Bhargava, U Ozbek, S Banavali, M A Chaudhary, H El Solh, K Bhatia.   

Abstract

Multiple genes have been shown to be independently hypermethylated in lymphoid malignancies. We report here on the extent of concurrent methylation of E-cadherin, Dap-kinase, O(6)MGMT, p73, p16, p15 and p14 in 129 pediatric ALL cases. While most of these genes demonstrated methylation in a proportion of cases, O(6)MGMT, p16 and p14 were infrequently methylated (11, 7 and 3%, respectively). Methylation of at least one gene was found in the vast majority (83%) of cases. To determine the extent and concordance of methylation we calculated a methylation index (MI=number of methylated genes/number of studied genes) for each sample. The average MI was 0.28, corresponding to 2/7 methylated genes. MI was correlated with standard prognostic factors, including immunophenotype, age, sex, WBC and presence of specific translocations (TEL-AML1, BCR-ABL, E2A-PBX1 or MLL-AF4). We determined that children >/=10 years old and children presenting with high WBC (>/=50 x 10(9)/l) both associated with a higher MI (P<0.01 and <0.05, respectively). T-ALLs demonstrated a lower MI (median=0.17) than precursor B ALLs (median=0.28). Among the different molecular subgroups, MLL-ALLs had the highest MI (mean=0.35), while ALLs carrying the t(1;19) had the lowest MI (mean=0.07). The most common epigenetic lesion in childhood ALL was methylation of E-cadherin (72%) independent of the molecular subtype or other clinicopathological factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970785     DOI: 10.1038/sj.leu.2403060

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  26 in total

1.  Genetic aberrations in childhood acute lymphoblastic leukaemia: application of high-density single nucleotide polymorphism array.

Authors:  Sarina Sulong
Journal:  Malays J Med Sci       Date:  2010-07

Review 2.  Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.

Authors:  Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

3.  DNA methyltransferase expression differs with proliferation in childhood acute lymphoblastic leukemia.

Authors:  Derya Beyza Sayin; Emin Kürekçi; Halil Gürhan Karabulut; Ustün Ezer; Isik Bökesoy
Journal:  Mol Biol Rep       Date:  2009-09-10       Impact factor: 2.316

4.  Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting.

Authors:  Eric Schafer; Rafael Irizarry; Sandeep Negi; Emily McIntyre; Donald Small; Maria E Figueroa; Ari Melnick; Patrick Brown
Journal:  Blood       Date:  2010-03-09       Impact factor: 22.113

Review 5.  Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.

Authors:  Oliver Galm; Manel Esteller
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

6.  DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia.

Authors:  W S Stevenson; O G Best; A Przybylla; Q Chen; N Singh; M Koleth; S Pierce; T Kennedy; W Tong; S-Q Kuang; G Garcia-Manero
Journal:  Leukemia       Date:  2013-09-18       Impact factor: 11.528

7.  Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia.

Authors:  Hui Yang; Tapan Kadia; Lianchun Xiao; Carlos E Bueso-Ramos; Koyu Hoshino; Deborah Ann Thomas; Susan O'Brien; Elias Jabbour; Sherry Pierce; Gary L Rosner; Hagop M Kantarjian; Guillermo Garcia-Manero
Journal:  Blood       Date:  2008-12-23       Impact factor: 22.113

Review 8.  Epigenetics of acute lymphocytic leukemia.

Authors:  Guillermo Garcia-Manero; Hui Yang; Shao-Qing Kuang; Susan O'Brien; Deborah Thomas; Hagop Kantarjian
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

Review 9.  The epigenome as a potential mediator of cancer and disease prevention in prenatal development.

Authors:  Pushpinder Kaur; Lyndsey E Shorey; Emily Ho; Roderick H Dashwood; David E Williams
Journal:  Nutr Rev       Date:  2013-05-15       Impact factor: 7.110

10.  Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia.

Authors:  Maria E Figueroa; Shann-Ching Chen; Anna K Andersson; Letha A Phillips; Yushan Li; Jason Sotzen; Mondira Kundu; James R Downing; Ari Melnick; Charles G Mullighan
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.